Skip to search formSkip to main contentSkip to account menu

MLN4924

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Lipin-2 degradation elicits a proinflammatory gene signature in macrophages.
2018
2018
MLN4924 suppresses lipopolysaccharide-induced proinflammatory cytokine production in neutrophils in a dose-dependent manner.
Neddylation is a ubiquitination-like pathway. It has been reported that neddylation inhibition with the pharmacological agent… 
2018
2018
Inhibition of neddylation facilitates cell migration through enhanced phosphorylation of caveolin-1 in PC3 and U373MG cells
Protein neddylation is a post-translational modification by a covalent conjugation with the neural precursor cell expressed… 
2016
2016
HIV-1 Vpr increases HCV replication through VprBP in cell culture.
2014
2014
Applications of Pathology-Assisted Image Analysis of Immunohistochemistry-Based Biomarkers in Oncology
Immunohistochemistry-based biomarkers are commonly used to understand target inhibition in key cancer pathways in preclinical… 
2011
2011
Azacitidine/Decitabine Synergism with the NEDD8-Activating Enzyme Inhibitor MLN4924 in Pre-Clinical AML Models
Abstract 578 MLN4924 is an investigational small molecule inhibitor of NEDD8-activating enzyme that has shown clinical activity… 
2011
2011
Stereoselective synthesis of MLN4924, an inhibitor of NEDD8-activating enzyme.
MLN4924 (1), which is in clinical trials as an anticancer agent, was stereoselectively synthesized from d-ribose via a route… 
2011
2011
MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, in patients (pts) with metastatic melanoma: Results of a phase I study.
8529 Background: MLN4924 is an investigational inhibitor of NAE; NAE is an essential controller of the NEDD8 conjugation pathway… 
2010
2010
The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study
Abstract 658 Background: NEDD8-activating enzyme (NAE) regulates the NEDD8 conjugation pathway, and is required for the activity… 
2009
2009
Phase 1 Dose-Escalation Study of MLN4924, a Novel NAE Inhibitor, in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.
Abstract 1854 Poster Board I-880 Background: MLN4924 is a first-in-class small molecule inhibitor of NEDD8-activating enzyme… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)